Best deals to access real time data! |
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Merck & Company (New) | MRK | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.51 | +0.66% | 77.93 | 77.94 | 77.92 | 77.92 | 77.42 | 09:30:22 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 111 | 8,422 | $ 77.9300 | $ 656.33k | 10.64M | 52.83 - 80.19 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:30:13 | 3 | $77.94 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Merck & Company (New) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 205.9B | 2.66B | $ 2.39B | 0.88 | 79.50 | 2.69B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.20 | 2.84% | 12/14/2018 | -31.11k | 5,621.50% |
Merck & Company (New) News
Current Report Filing (8-k) Edgar (US Regulatory) • Mon Dec 10, 2018 5:25 PM (16 hours ago)
Merck President of Global Human Health to Step Down Dow Jones News • Mon Dec 10, 2018 5:25 PM (16 hours ago)
Merck’s President of Global Human Health Adam H. Schechter to Leave Merck Frank Clyburn Named Chief Commercial Officer & Mi... Business Wire • Mon Dec 10, 2018 4:30 PM (17 hours ago)
Moderna Declines in Market Debut -- WSJ Dow Jones News • Sat Dec 08, 2018 3:02 AM (3 days ago)
Moderna Declines in Public-Market Debut -- Update Dow Jones News • Fri Dec 07, 2018 6:21 PM (4 days ago)
Moderna Declines in Public-Market Debut Dow Jones News • Fri Dec 07, 2018 1:07 PM (4 days ago)
BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safet... GlobeNewswire Inc. • 
• Thu Dec 06, 2018 8:30 AM (5 days ago)
• Thu Dec 06, 2018 8:30 AM (5 days ago)|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 79.3 | 80.19 | 75.82 | 77.6863 | 13M | 15M | 14M | -1.37 | -1.73% |
| 1 Month | 75.22 | 80.19 | 73.13 | 76.7523 | 4M | 20M | 12M | 2.71 | 3.60% |
| 3 Months | 70.41 | 80.19 | 66.1 | 73.5346 | 4M | 20M | 11M | 7.52 | 10.68% |
| 6 Months | 62.37 | 80.19 | 59.8 | 69.6447 | 4M | 20M | 9M | 15.56 | 24.95% |
| 1 Year | 56.87 | 80.19 | 52.83 | 63.0054 | 4M | 48M | 10M | 21.06 | 37.03% |
| 3 Years | 52.48 | 80.19 | 47.97 | 60.7692 | 3M | 69M | 9M | 25.45 | 48.49% |
| 5 Years | 47.93 | 80.19 | 45.69 | 58.9814 | 3M | 69M | 10M | 30 | 62.59% |
Merck & Company (New) Description
| Merck & Co Inc is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. |
